Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1375706 | 1.00 | PPARA (0.53) | PPARAFAAHTRPV1EPHX2 | |
| SCHEMBL302734 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL148471 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL9660696 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL76962 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL146003 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL9661841 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL149027 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL10873634 | 0.87 | EPHX1 (0.48) | PPARA | |
| SCHEMBL9661664 | 0.87 | EPHX1 (0.48) | PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150202179-A1 | FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS | YISSUM RES DEV CO (IL) | 2015-07-23 | — | — | US | claimed |
| WO-2014013497-A1 | FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-01-23 | — | — | WO | claimed |
| CN-110022895-A | therapeutic compositions and methods for treating hepatitis B | 阿布特斯生物制药公司 | 2019-07-16 | — | — | CN | disclosed |
| WO-2014013497-A1 | FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2014-01-23 | — | — | WO | disclosed |
| US-6433223-B1 | HYDROXYLAMINE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 2002-08-13 | — | — | US | disclosed |
| US-6057090-A | Silver halide photographic material and hydroxamic acid-based compound used therefor | FUJI PHOTO FILM CO., LTD. (JP) | 2000-05-02 | — | — | US | disclosed |
| US-4052214-A | COLOR DIFFUSION TRANSFER PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL FOR FORMING BOTH POSITIVE TRANSFER DYE IMAGES AND NEGATIVE DYE IMAGES | FUJI PHOTO FILM CO., LTD. (JA) | 1977-10-04 | — | — | US | disclosed |
| US-4015989-A | Color light-sensitive material with spontaneously developable silver halide emulsion containing desensitizing dye | FUJI PHOTO FILM CO., LTD. (JA) | 1977-04-05 | — | — | US | disclosed |
| US-3960569-A | Diffusion transfer color film unit with hydroxy substituted alkylene amino development accelerators | FUJI PHOTO FILM CO., LTD. (JA) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202179-A1 | FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS | ALOX5, FFAR2, FASN | PPARA 27/4885FAAH 10/4885TRPV1 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.